Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Malignant pleural mesothelioma: 2013 state of the art].

Bulletin du cancer - 1 Dec 2013

Campbell Karine, Brosseau Solenn, Reviron-Rabec Lucie, Bergot Emmanuel, Lechapt Emmanuèle, Levallet Guénaëlle, Zalcman Gérard

Abstract excerpt

Malignant pleural mesothelioma (MPM) is a bad-prognosis cancer raising difficult issues according to diagnosis. Reliable histological diagnosis indeed requires large-sized pathological samples obtained by thoracoscopy, and need diagnosis certification by the MESOPATH national expert pathological committee. MPM epidemiology shows a rising incidence among females, whereas an incidence plateau has been reached for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Bevacizumab

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glutamates

Share to Mesothelioma

Share to Mesothelioma, Malignant

Share to Pemetrexed

Share to Pleural Neoplasms

Share to Ubiquitin Thiolesterase

Source

Identifiers

PMID: 24225007
DOI: 10.1684/bdc.2013.1857

Genes

BAP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Malignant pleural mesothelioma: 2013 state of the art].PMID 24225007Read ↗

Progress and challenges in Mesothelioma: From bench to bedside.Semantic proximity Read ↗

Integrating Data from Multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort studySemantic proximity Read ↗

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.Semantic proximity Read ↗

Intrapleural injection of Folactis promotes regression of malignant pleural effusion: a case of malignant pleural mesothelioma and the review of literaturesSemantic proximity Read ↗

Multiple institutions’ research findings using the National Mesothelioma Virtual BankSemantic proximity Read ↗

Molecular pathogenesis of malignant mesotheliomaSemantic proximity Read ↗

Management of malignant pleural mesothelioma.Semantic proximity Read ↗

BAP1 Loss Predicts Therapeutic Vulnerability in Malignant Peritoneal MesotheliomaSemantic proximity Read ↗

Integrative Molecular Characterization of Malignant Pleural Mesothelioma.Semantic proximity Read ↗

Genomics and Functional Genomics of Malignant Pleural MesotheliomaSemantic proximity Read ↗

Multimodality treatment of malignant pleural mesotheliomaSemantic proximity Read ↗

Pleural effusion in lung cancer: more questions than answers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.